Azodisalicylate (Olsalazine) in the treatment of active ulcerative colitis. A placebo controlled clinical trial and assessment of drug disposition
- 1 June 1986
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 1 (3), 257-266
- https://doi.org/10.1111/j.1440-1746.1986.tb00121.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Absorption and Excretion of a Single 1-g Dose of Azodisal Sodium in Subjects with IleostomyScandinavian Journal of Gastroenterology, 1983
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980
- Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.Gut, 1980
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1977
- A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin)Gut, 1973
- Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator PhenotypeNew England Journal of Medicine, 1973
- Absorption, metabolism, and excretion of salicylazosulfapyridine in manClinical Pharmacology & Therapeutics, 1972
- CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITISThe Lancet, 1965
- Controlled trial of sulphasalazine in the treatment of ulcerative colitisGut, 1964
- SULPHASALAZINE AND SALICYLAZOSULPHADIMIDINE IN ULCERATIVE COLITISThe Lancet, 1962